Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by Regulating PDCD4

Molecular and Cellular Biology

Volumn 32, Issue 20, 2012, Pages 4237-4244

  Park, Young Mi ^a   Hwang, Su Jin ^a   Masuda, Kiyoshi ^c   Choi, Kyung Min ^d   Jeong, Mi Ran ^d   Nam, Do Hyun ^e   Gorospe, Myriam ^c   Kim, Hyeon Ho ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Institute of Jinan Red Ginseng   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; MEMBRANE PROTEIN; MICRORNA; PROGRAMMED CELL DEATH 4; PROTEIN KINASE B; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CANCER GRADING; CELL PROLIFERATION; DOWN REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOBLASTOMA; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP C; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; ONCOGENE PROTEIN V-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA-BINDING PROTEINS;

EID: 84868713197     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00443-12     Document Type: Article

References (49)

1. Asangani IA, et al. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136.
2. Bitomsky N, Bohm M, Klempnauer KH. 2004. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23:7484-7493.
3. Bitomsky N, Wethkamp N, Marikkannu R, Klempnauer KH. 2008. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression. Oncogene 27:4820-4829.
4. Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655.
5. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65:6029-6033.
6. Chen Y, et al. 2003. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J. Pathol. 200:640-646.
7. Chien CH, et al. 2011. Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res. 39:9345-9356.
8. Choi YD, Grabowski PJ, Sharp PA, Dreyfuss G. 1986. Heterogeneous nuclear ribonucleoproteins: role inRNAsplicing. Science 231:1534-1539.
9. Christian KJ, Lang MA, Raffalli-Mathieu F. 2008. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment. Mol. Pharmacol. 73:1558-1567.
10. Cmarik JL, et al. 1999. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. U. S. A. 96:14037-14042.
11. Connolly EC, Van Doorslaer K, Rogler LE, Rogler CE. 2010. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol. Cancer Res. 8:691-700.
12. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. 2008. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7:2643-2646.
13. Dorrello NV, et al. 2006. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314:467-471.
14. Fujita S, et al. 2008. miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378: 492-504.
15. Gao F, et al. 2009. PDCD4 gene silencing in gliomas is associated with 5=CpG island methylation and unfavourable prognosis. J. Cell. Mol. Med. 13:4257-4267.
16. Gao F, et al. 2007. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol. Rep. 17:123-128.
17. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. 2006. MicroRNA expression and function in cancer. Trends Mol. Med. 12:580-587.
18. Gaur AB, Holbeck SL, Colburn NH, Israel MA. 2011. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 13:580-590.
19. Goke R, et al. 2004. Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann. N. Y. Acad. Sci. 1014:220-221.
20. Huang TH, et al. 2009. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J. Biol. Chem. 284:18515-18524.
21. Iorio MV, et al. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065-7070.
22. Jin X, et al. 2011. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 71:3066-3075.
23. Kim HH, et al. 2009. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 23:1743-1748.
24. Kim JH, et al. 2003. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell. Biol. 23:708-720.
25. Krichevsky AM, Gabriely G. 2009. miR-21: a small multi-faceted RNA. J. Cell. Mol. Med. 13:39-53.
26. Lankat-Buttgereit B, Goke R. 2009. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol. Cell 101:309-317.
27. Lankat-Buttgereit B, et al. 2004. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol. Cell. Endocrinol. 214: 149-153.
28. Lee EK, et al. 2010. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat. Struct. Mol. Biol. 17:732-739.
29. Leupold JH, et al. 2007. Tumor suppressor Pdcd4 inhibits invasion/ intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26:4550-4562.
30. Li Y, et al. 2009. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res. 1286:13-18.
31. Louis DN. 2006. Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 1:97-117.
32. Lunde BM, Moore C, Varani G. 2007. RNA-binding proteins: modular design for efficient function. Nat. Rev. Mol. Cell. Biol. 8:479-490.
33. Michlewski G, Caceres JF. 2010. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat. Struct. Mol. Biol. 17: 1011-1018.
34. Michlewski G, Guil S, Semple CA, Caceres JF. 2008. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Mol. Cell 32: 383-393.
35. Palamarchuk A, et al. 2005. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res. 65:11282-11286.
36. Pinol-Roma S, Dreyfuss G. 1993. hnRNP proteins: localization and transport between the nucleus and the cytoplasm. Trends Cell Biol. 3:151-155.
37. Reis PP, et al. 2010. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol. Cancer 9:238.
38. Roldo C, et al. 2006. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 24:4677-4684.
39. Shetty S. 2005. Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells. Mol. Cell. Biochem. 272:107-118.
40. Si ML, et al. 2007. miR-21-mediated tumor growth. Oncogene 26:2799-2803.
41. Trabucchi M, et al. 2009. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459:1010-1014.
42. van Kouwenhove M, Kedde M, Agami R. 2011. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat. Rev. Cancer 11:644-656.
43. Volinia S, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261.
44. Wei N, Liu SS, Chan KK, Ngan HY. 2012. Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer. PLoS One 7:e30311. doi:10.1371/journal.pone.0030311.
45. Wei NA, et al. 2009. Loss of programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol. Cancer 8:70.
46. Yang HS, et al. 2006. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell. Biol 26:1297-1306.
47. Zhang X, Wan G, Berger FG, He X, Lu X. 2011. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41:371-383.
48. Zhou X, et al. 2010. Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol. Rep. 24:195-201.
49. Zhu S, et al. 2008. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18:350-359.